Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
- Lancet, Available online 18 July 2022, Version of Record 28 July 2022. | https://doi.org/10.1016/S0140-6736(22)00916-3